top of page
Recent Posts

New chemical technology leads to better targeted therapeutics against high-risk leukemia in the lab

Scientists from St. Jude Children’s Research Hospital have created an LCK targeted PROTAC, demonstrating its enhanced ability to kill T-cell acute lymphoblastic leukemia cells.


Archive
Search By Tags
bottom of page